Toll-like receptors in infectious myocarditis: pathogen-specific recognition, spatiotemporal dynamic regulation and

Yuhua Li1, Weiming Liao2, Qingfei Liang3

  • 1Department of Pharmacy, The First Naval Hospital of Southern Theatre Command, Zhanjiang, Guangdong, China.

Insights

Toll-like receptor (TLR) activation dictates infectious myocarditis severity and progression. Understanding pathogen-TLR matching and TLR signaling dynamics is crucial for developing targeted therapies and improving patient outcomes.

Area of Science:

  • Cardiovascular Immunology
  • Infectious Diseases
  • Innate Immunity

Background:

  • Infectious myocarditis presents diverse clinical outcomes and high mortality rates, influenced by causative agents like COVID-19, influenza, and sepsis.
  • Toll-like receptors (TLRs) are central to innate immunity, orchestrating inflammatory responses from pathogen recognition to chronic tissue remodeling in myocarditis.
  • Current research often overlooks the specific pathogen-TLR interactions and the dynamic, time-dependent regulation of TLR signaling throughout myocarditis progression.

Purpose of the Study:

  • To systematically review the epidemiological data of infectious myocarditis.
  • To elucidate the role of Toll-like receptor (TLR) family signaling in the cardiac immune microenvironment during disease progression.
  • To analyze pathogen-specific TLR recognition and the spatiotemporal regulation of TLR signaling pathways.

Main Methods:

  • Comprehensive literature review of epidemiological profiles and clinical data on infectious myocarditis.
  • Analysis of TLR expression patterns and signaling mechanisms within the cardiac immune milieu.
  • Examination of pathogen-specific recognition modes and TLR signaling dynamics across different disease stages (acute inflammation, immune deviation, chronic fibrosis).

Main Results:

  • Pathogen-TLR matching is a key determinant of inflammatory phenotypes and disease severity in infectious myocarditis.
  • The spatiotemporal dynamics of TLR signaling critically govern the progression of myocarditis.
  • Effective TLR-targeted therapies require pathogen specificity and precise, stage-specific regulation.

Conclusions:

  • Pathogen-TLR interactions and the dynamic regulation of TLR signaling are fundamental to understanding infectious myocarditis.
  • This review provides a theoretical framework for precise immunodiagnosis and individualized immunotherapy strategies for infectious myocarditis.
  • Targeting TLRs necessitates a nuanced approach considering pathogen type and disease stage for optimal therapeutic outcomes.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...